Gustaaf W van Imhoff Selected Research

Gustaaf W van Imhoff Research Topics

Disease

7	Hodgkin Disease (Hodgkin's Disease) 01/2020 - 04/2006
7	Lymphoma (Lymphomas) 12/2017 - 04/2006
5	Neoplasms (Cancer) 01/2019 - 03/2012
5	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2010 - 06/2005
3	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2021 - 08/2008
3	B-Cell Lymphoma (Lymphoma, B Cell) 12/2020 - 02/2011
3	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 11/2019 - 09/2006
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2020 - 08/2015
2	Bronchiolitis Obliterans Syndrome 01/2020 - 01/2002
2	Second Primary Neoplasms (Neoplasms, Second) 12/2015 - 01/2015
2	Multiple Myeloma 01/2010 - 05/2005
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 10/2008 - 03/2007
2	Pathologic Complete Response 01/2008 - 01/2002
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020
1	Breast Neoplasms (Breast Cancer) 12/2015
1	Premature Menopause 12/2015
1	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2015
1	Thyroid Neoplasms (Thyroid Cancer) 10/2015
1	Leukemia 08/2015
1	Body Weight (Weight, Body) 10/2014
1	Infections 11/2013
1	Sepsis (Septicemia) 10/2013
1	Lymphomatoid Granulomatosis (Granulomatosis, Lymphomatoid) 10/2013
1	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2012
1	Asthma (Bronchial Asthma) 02/2012
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 10/2011
1	Genetic Translocation (Chromosomal Translocation) 02/2011
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2008
1	T-Cell Lymphoma (Lymphoma, T Cell) 08/2008
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2002
1	Aspergillosis 01/2002

Drug/Important Bio-Agent (IBA)

5	Rituximab (Mabthera)FDA Link 12/2020 - 01/2002
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2020 - 05/2005
3	Vincristine (Oncovin)FDA LinkGeneric 12/2020 - 04/2007
3	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2020 - 04/2007
2	Alemtuzumab (Campath)FDA Link 01/2021 - 08/2008
2	Chemokine CCL17IBA 01/2020 - 03/2012
2	Dexamethasone (Maxidex)FDA LinkGeneric 12/2017 - 02/2017
2	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2017 - 02/2017
2	Biomarkers (Surrogate Marker)IBA 12/2016 - 03/2012
2	Proteins (Proteins, Gene)FDA Link 10/2011 - 09/2006
2	Prednisone (Sone)FDA LinkGeneric 08/2008 - 04/2007
1	Prednisolone (Predate)FDA LinkGeneric 12/2020
1	Lenalidomide (CC 5013)FDA Link 12/2020
1	Methotrexate (Mexate)FDA LinkGeneric 12/2017
1	ofatumumab FDA Link 02/2017
1	Cisplatin (Platino)FDA LinkGeneric 02/2017
1	Immune Checkpoint InhibitorsIBA 01/2017
1	invariant chain (Ii-Key)IBA 01/2017
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	Galectin 1 (LGALS1)IBA 12/2016
1	mogamulizumabIBA 10/2016
1	Monoclonal AntibodiesIBA 10/2016
1	Procarbazine (Matulane)FDA Link 12/2015
1	Dimethyl Sulfoxide (DMSO)FDA LinkGeneric 10/2014
1	Melphalan (Alkeran)FDA LinkGeneric 10/2014
1	Antiviral Agents (Antivirals)IBA 11/2013
1	Deoxyglucose (2 Deoxy D glucose)IBA 03/2012
1	ImmunosorbentsIBA 03/2012
1	EnzymesIBA 03/2012
1	Interleukin-13IBA 02/2012
1	CryoglobulinsIBA 10/2011
1	Rheumatoid FactorIBA 10/2011
1	Immunoglobulin M (IgM)IBA 10/2011
1	Biological ProductsIBA 02/2011
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2007
1	Thalidomide (Thalomid)FDA Link 05/2005

Therapy/Procedure

9	Therapeutics 12/2020 - 06/2005
9	Stem Cell Transplantation 01/2020 - 06/2005
8	Drug Therapy (Chemotherapy) 01/2019 - 04/2006
4	Transplantation 08/2015 - 04/2006
3	Radiotherapy 01/2019 - 12/2015
3	Aftercare (After-Treatment) 12/2015 - 01/2002
2	Splenectomy 01/2021 - 01/2015
2	Organ Transplantation 10/2008 - 03/2007
1	Salvage Therapy 02/2017
1	Surgical Instruments (Clip) 01/2017
1	Autologous Transplantation 10/2014
1	Hematopoietic Stem Cell Transplantation 10/2013
1	Retreatment 10/2011
1	Remission Induction 01/2008
1	Induction Chemotherapy 04/2006